HLS Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) Transcript
So my name is Rahul Sarugaser. I'm a MedTech, biotech analyst out of the Raymond James Toronto office. Today we have the pleasure of HLS Therapeutics presenting on the Raymond James Health Innovations Conference, and we have CEO and CFO, respectively, Gilbert Godin and Tim Hendrickson.
This is a Company in which we really have some growing conviction, particularly off the back of the ramp of the commercialization of Vascepa in Canada. The ramp has been well in line with what we've expected despite COVID headwinds and so we are anticipating a relatively good ramp in the back half of the year really be [foreloaded], and that portends, in our view, a really strong 2022. And so this is a story that we are indeed highlighting for our clients.
So, of course, Gilbert does a far better job of telling the story than I do. So I will hand the reins to him. Gilbert?
Good. I bet I could (inaudible) that last statement. Thank you, Rahul, for the kind
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
